Trigger factors of cutaneous lupus erythematosus: a review of current literature.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 791, doi. 10.1177/0961203317691369
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2017 AND VI 26 AND IP 8
Results: 16
1
2
Infodemiology of systemic lupus erythematous using Google Trends.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 886, doi. 10.1177/0961203317691372
- By:
- Publication type:
- Article
3
Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 871, doi. 10.1177/0961203316686845
- By:
- Publication type:
- Article
4
Retrospective review of lupus nephritis in a New Zealand multi-ethnic cohort.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 893, doi. 10.1177/0961203316686701
- By:
- Publication type:
- Article
5
Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 881, doi. 10.1177/0961203316686700
- By:
- Publication type:
- Article
6
Drug-induced lupus erythematosus mimicking lymphoma on <sup>18</sup>F-FDG-PET/CT.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
7
Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 865, doi. 10.1177/0961203316682101
- By:
- Publication type:
- Article
8
The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 849, doi. 10.1177/0961203316682100
- By:
- Publication type:
- Article
9
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 835, doi. 10.1177/0961203316682099
- By:
- Publication type:
- Article
10
Belimumab for the treatment of recalcitrant cutaneous lupus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 857, doi. 10.1177/0961203316682097
- By:
- Publication type:
- Article
11
Review by Hui-Yuen et al. Targeted B-cell therapies in the treatment of adult and paediatric systemic lupus erythematosus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 900, doi. 10.1177/0961203316680894
- By:
- Publication type:
- Article
12
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 841, doi. 10.1177/0961203316679528
- By:
- Publication type:
- Article
13
Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 825, doi. 10.1177/0961203316678675
- By:
- Publication type:
- Article
14
Zika virus (ZIKV) infection related with immune thrombocytopenic purpura (ITP) exacerbation and antinuclear antibody positivity.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
15
Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 808, doi. 10.1177/0961203316678673
- By:
- Publication type:
- Article
16
Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
- Published in:
- Lupus, 2017, v. 26, n. 8, p. 815, doi. 10.1177/0961203316678674
- By:
- Publication type:
- Article